Reading, MA, United States of America

Karen Westerman

USPTO Granted Patents = 10 


Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 120(Granted Patents)


Company Filing History:


Years Active: 1999-2023

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Karen Westerman - Innovator in Gene Therapy

Introduction

Karen Westerman is a prominent inventor based in Reading, MA (US), known for her significant contributions to the field of gene therapy. With a total of 10 patents to her name, she has made remarkable advancements in therapeutic retroviral vectors aimed at treating hematopoietic-related disorders.

Latest Patents

Westerman's latest patents focus on improved compositions and methods for achieving gene therapy in hematopoietic cells and hematopoietic precursor cells, including erythrocytes, erythroid progenitors, and embryonic stem cells. These inventions provide enhanced gene therapy methods specifically designed for treating hematopoietic-related disorders, particularly those related to hemoglobinopathic conditions.

Career Highlights

Throughout her career, Karen has worked with leading organizations such as Bluebird Bio, Inc. and the Massachusetts Institute of Technology. Her work has been instrumental in advancing the understanding and application of gene therapy techniques.

Collaborations

Westerman has collaborated with notable colleagues in her field, including Philippe Leboulch and Robert Pawliuk. These partnerships have further enriched her research and innovation efforts.

Conclusion

Karen Westerman's contributions to gene therapy exemplify her dedication to improving medical treatments for hematopoietic disorders. Her innovative work continues to inspire advancements in the field, making her a key figure in the realm of biotechnology

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…